BIOMAT Database Logo BIOMAT Database Logo

Comment: enoxaparin--the low-molecular-weight heparin for prevention of postoperative thromboembolic complications. 1994

E Saltiel, and F Saya

UI MeSH Term Description Entries
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin
D017984 Enoxaparin Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed) Clexane,EMT-966,EMT-967,Enoxaparine,Lovenox,PK-10,169,PK-10169,EMT 966,EMT 967,EMT966,EMT967,PK 10,169,PK 10169,PK10,169,PK10169

Related Publications

E Saltiel, and F Saya
Enoxaparin: the low-molecular-weight heparin for prevention of postoperative thromboembolic complications.
October 1993, The Annals of pharmacotherapy,
E Saltiel, and F Saya
[Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
January 2001, Anesteziologiia i reanimatologiia,
E Saltiel, and F Saya
[Anti-Xa activity during administration of low-molecular weight heparin in the prevention of postoperative thromboembolic complications].
December 1999, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,
E Saltiel, and F Saya
Prevention of thrombotic complications of the nephrotic syndrome by the low-molecular-weight heparin enoxaparin.
January 1995, Nephron,
E Saltiel, and F Saya
Low molecular weight heparin for prevention of thromboembolic complications in cardioversion--rationale and design of the ACE study (Anticoagulation in Cardioversion using Enoxaparin).
March 2002, Zeitschrift fur Kardiologie,
E Saltiel, and F Saya
Subcutaneous low dose heparin in the prevention of postoperative thromboembolic complications.
April 1976, Journal of the Oslo city hospitals,
E Saltiel, and F Saya
Enoxaparin--a low-molecular-weight heparin.
August 1993, The Medical letter on drugs and therapeutics,
E Saltiel, and F Saya
Prevention of Thromboembolic Complications After Spine Surgery by the Use of Low-Molecular-Weight Heparin.
August 2017, World neurosurgery,
E Saltiel, and F Saya
[Perioperative prevention of thromboembolism with low molecular weight heparin and postoperative bleeding complications].
January 1990, Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress,
E Saltiel, and F Saya
Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin.
November 1989, The British journal of clinical practice,
Copied contents to your clipboard!